chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: Muscle pain in both legs; This spontaneous case was reported by a health care professional and describes the occurrence of MYALGIA (Muscle pain in both legs) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination.     Concurrent medical conditions included Autoimmune disorder. Concomitant products included SPIRONOLACTONE, TOPIRAMATE (TOPAMAX), PROGESTERONE, TESTOSTERONE and METFORMIN for an unknown indication.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Jan-2021, the patient experienced MYALGIA (Muscle pain in both legs). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, MYALGIA (Muscle pain in both legs) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded. Further information has been requested
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Nasal congestion, Sneezing
Clinical narrative: Sneezing; Congested all last night; This spontaneous case was reported by a consumer and describes the occurrence of SNEEZING and NASAL CONGESTION in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Feb-2021, the patient experienced NASAL CONGESTION. On an unknown date, the patient experienced SNEEZING. At the time of the report, SNEEZING and NASAL CONGESTION outcome was unknown. Not Provided.       The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was unknown.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Nausea
Clinical narrative: Headache; Nausea; This spontaneous case was reported by a patient and describes the occurrence of HEADACHE (Headache) and NAUSEA (Nausea) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, the patient experienced HEADACHE (Headache) and NAUSEA (Nausea). At the time of the report, HEADACHE (Headache) and NAUSEA (Nausea) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Myalgia, Vaccination site mass
Clinical narrative: Lump appeared in the collar bone/a lump appeared in the clavicle in the same side where the vaccine; Swollen lymph/ May be a swollen gland; Achy; A spontaneous report was received from a healthcare professional concerning a 64-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events lump appeared in the collar bone, lump appeared in the clavicle in the same side where the vaccine was administered, swollen gland, swollen lymph/ Lymphadenopathy and achy/Myalgia.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 9 Jan 2021, prior to the onset of the events the patient received second of two planned doses of mRNA-1273 (lot/batch: 030420A) via unknown route in the left arm for prophylaxis of COVID-19 infection.  On 6 Feb 2021, after receiving the second dose, the patient experienced a lump appeared in the clavicle in the same side where the vaccine was administered, swollen lymph, it may be a swollen gland and achy. The patient informed that lump was getting smaller. The patient treated the events with Ibuprofen .  Action taken with mRNA-1273 in response to the events was unknown.   The outcome of event for the event lump appeared in the collar bone was resolving.  The outcome of event for the event swollen lymph, it may be a swollen gland and achy was unknown.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: COVID-19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (COVID-19) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (COVID-19). At the time of the report, COVID-19 (COVID-19) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Hyperhidrosis, Myalgia, Nausea
Clinical narrative: Sweaty; Fever, like 102.9; Nausea; Body ache; Chills; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (Sweaty), PYREXIA (Fever, like 102.9), NAUSEA (Nausea), MYALGIA (Body ache) and CHILLS (Chills) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025120A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Jan-2021, the patient experienced HYPERHIDROSIS (Sweaty), PYREXIA (Fever, like 102.9), NAUSEA (Nausea), MYALGIA (Body ache) and CHILLS (Chills). At the time of the report, HYPERHIDROSIS (Sweaty), PYREXIA (Fever, like 102.9), NAUSEA (Nausea), MYALGIA (Body ache) and CHILLS (Chills) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 15-Jan-2021, Body temperature: 102.9 (High) 102.9.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.  No treatment information was provided.    Most recent FOLLOW-UP information incorporated above includes: On 07-Apr-2021: Follow-up information received on 07 Apr 2021.Added reporter details, second dose details and updated outcome of events.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Sweaty; Fever, like 102.9; Nausea; Body ache; Chills; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (Sweaty), PYREXIA (Fever, like 102.9), NAUSEA (Nausea), MYALGIA (Body ache) and CHILLS (Chills) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025120A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Jan-2021, the patient experienced HYPERHIDROSIS (Sweaty), PYREXIA (Fever, like 102.9), NAUSEA (Nausea), MYALGIA (Body ache) and CHILLS (Chills). At the time of the report, HYPERHIDROSIS (Sweaty), PYREXIA (Fever, like 102.9), NAUSEA (Nausea), MYALGIA (Body ache) and CHILLS (Chills) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 15-Jan-2021, Body temperature: 102.9 (High) 102.9.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.  No treatment information was provided.    Most recent FOLLOW-UP information incorporated above includes: On 07-Apr-2021: Follow-up information received on 07 Apr 2021.Added reporter details, second dose details and updated outcome of events.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Peripheral swelling, Pruritus, Rash macular
Clinical narrative: Swollen, Arm is bigger than normal; It is itchy; Arm was pink red Blotch; arm was sore; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Swollen, Arm is bigger than normal), PRURITUS (It is itchy), MYALGIA (arm was sore) and RASH MACULAR (Arm was pink red Blotch) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 02AL20A) for COVID-19 vaccination.     The patient's past medical history included Shoulder replacement.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Jan-2021, the patient experienced MYALGIA (arm was sore). On 05-Feb-2021, the patient experienced PERIPHERAL SWELLING (Swollen, Arm is bigger than normal), PRURITUS (It is itchy) and RASH MACULAR (Arm was pink red Blotch). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and HYDROCORTISONE at an unspecified dose and frequency. On 02-Feb-2021, MYALGIA (arm was sore) had resolved. At the time of the report, PERIPHERAL SWELLING (Swollen, Arm is bigger than normal), PRURITUS (It is itchy) and RASH MACULAR (Arm was pink red Blotch) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.  Treatment details included  Ice, Exercise.   Most recent FOLLOW-UP information incorporated above includes: On 19-Jun-2021: Follow up received on 19-JUN-2021 contains no newinformation.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Injection site pain, Pain
Clinical narrative: Dizziness; Aches; Pain; Arm is still sore at injection site; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness), PAIN (Aches), PAIN (Pain) and INJECTION SITE PAIN (Arm is still sore at injection site) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history). Concomitant products included AMLODIPINE, LISINOPRIL, ATORVASTATIN CALCIUM and ACETYLSALICYLIC ACID (BABY ASPIRIN) for an unknown indication.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Feb-2021, the patient experienced DIZZINESS (Dizziness), PAIN (Aches), PAIN (Pain) and INJECTION SITE PAIN (Arm is still sore at injection site). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, DIZZINESS (Dizziness), PAIN (Aches), PAIN (Pain) and INJECTION SITE PAIN (Arm is still sore at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Bad rash on stomach; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Bad rash on stomach) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Jan-2021, the patient experienced RASH (Bad rash on stomach). On 25-Jan-2021, RASH (Bad rash on stomach) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Pyrexia
Clinical narrative: fever; body ache; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever) and MYALGIA (body ache) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011L20A and 012M20A) for COVID-19 vaccination.     Concurrent medical conditions included Multiple sclerosis in October 2019. Concomitant products included DIMETHYL FUMARATE (TECFIDERA) for an unknown indication.   On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-Feb-2021, the patient experienced PYREXIA (fever) and MYALGIA (body ache). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 06-Feb-2021, PYREXIA (fever) and MYALGIA (body ache) had resolved. Not Provided
Age: 99.0
Sex: U
Vaccine: COVID19
Symptoms: Vaccination site rash
Clinical narrative: Herpes-Like Rash on the injection arm; This spontaneous case was reported by a nurse and describes the occurrence of VACCINATION SITE RASH (Herpes-Like Rash on the injection arm) in a 99-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History was provided by the reporter.  Previously administered products included for an unreported indication: SHINGRIX.   On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On 15-Jan-2021, the patient experienced VACCINATION SITE RASH (Herpes-Like Rash on the injection arm). The patient was treated with VALACICLOVIR HYDROCHLORIDE (VALTREX) for Adverse event, at an unspecified dose and frequency.   At the time of the report, VACCINATION SITE RASH (Herpes-Like Rash on the injection arm) had resolved.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 23-Apr-2021: Reporter information updated.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Dyskinesia, Swelling
Clinical narrative: swelling; right leg wouldn't move from the knee to the foot/I couldn't move my legs, like they were tightened together; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (swelling) and DYSKINESIA (right leg wouldn't move from the knee to the foot/I couldn't move my legs, like they were tightened together) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, the patient experienced SWELLING (swelling) and DYSKINESIA (right leg wouldn't move from the knee to the foot/I couldn't move my legs, like they were tightened together). At the time of the report, SWELLING (swelling) outcome was unknown and DYSKINESIA (right leg wouldn't move from the knee to the foot/I couldn't move my legs, like they were tightened together) had resolved. Not Provided          No relevant concomitant medications were reported. Treatment details included Not provided.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Epistaxis
Clinical narrative: Nose bleed vey bad; This spontaneous case was reported by a consumer and describes the occurrence of EPISTAXIS in an 80-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20a) for COVID-19 vaccination.     Concomitant products included LIPITOR, PROSCAR, JANUVIA, and ASPIRIN for an unknown indication.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, the patient experienced EPISTAXIS. At the time of the report, EPISTAXIS had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Sensitive skin, Vaccination site erythema, Vaccination site swelling
Clinical narrative: redness; sensitive; swelling; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (redness), SENSITIVE SKIN (sensitive) and VACCINATION SITE SWELLING (swelling) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID), NORTRIPTYLINE and LORAZEPAM (ATIVAN) for an unknown indication.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, the patient experienced VACCINATION SITE ERYTHEMA (redness), SENSITIVE SKIN (sensitive) and VACCINATION SITE SWELLING (swelling). At the time of the report, VACCINATION SITE ERYTHEMA (redness), SENSITIVE SKIN (sensitive) and VACCINATION SITE SWELLING (swelling) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment details included None.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Hyperhidrosis, Oedema peripheral, Peripheral swelling
Clinical narrative: 2 large spot where the injection went in it almost looks like have 2; feet is wider; Right foot and calf is swollen; sweating; Chills; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of OEDEMA PERIPHERAL (feet is wider), HYPERHIDROSIS (sweating), PERIPHERAL SWELLING (Right foot and calf is swollen), VACCINATION COMPLICATION (2 large spot where the injection went in it almost looks like have 2) and CHILLS (Chills) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No reported medical history). Concomitant products included LEVOTHYROXINE SODIUM (UNITHROID), CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000), OXYBUTYNIN, ACETYLSALICYLIC ACID (BABY ASPIRIN), VITAMIN C [ASCORBIC ACID], ATENOLOL, LISINOPRIL, MONTELUKAST, SIMVASTATIN and ZINC for an unknown indication.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Feb-2021, the patient experienced HYPERHIDROSIS (sweating), CHILLS (Chills) and FATIGUE (fatigue). On 08-Feb-2021, the patient experienced OEDEMA PERIPHERAL (feet is wider) and PERIPHERAL SWELLING (Right foot and calf is swollen). On 10-Feb-2021, the patient experienced VACCINATION COMPLICATION (2 large spot where the injection went in it almost looks like have 2). On 08-Feb-2021, HYPERHIDROSIS (sweating) and CHILLS (Chills) had resolved. On 10-Feb-2021, FATIGUE (fatigue) had resolved. At the time of the report, OEDEMA PERIPHERAL (feet is wider), PERIPHERAL SWELLING (Right foot and calf is swollen) and VACCINATION COMPLICATION (2 large spot where the injection went in it almost looks like have 2) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment details include stockings.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: 2 large spot where the injection went in it almost looks like have 2; feet is wider; Right foot and calf is swollen; sweating; Chills; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of OEDEMA PERIPHERAL (feet is wider), HYPERHIDROSIS (sweating), PERIPHERAL SWELLING (Right foot and calf is swollen), VACCINATION COMPLICATION (2 large spot where the injection went in it almost looks like have 2) and CHILLS (Chills) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No reported medical history). Concomitant products included LEVOTHYROXINE SODIUM (UNITHROID), CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000), OXYBUTYNIN, ACETYLSALICYLIC ACID (BABY ASPIRIN), VITAMIN C [ASCORBIC ACID], ATENOLOL, LISINOPRIL, MONTELUKAST, SIMVASTATIN and ZINC for an unknown indication.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Feb-2021, the patient experienced HYPERHIDROSIS (sweating), CHILLS (Chills) and FATIGUE (fatigue). On 08-Feb-2021, the patient experienced OEDEMA PERIPHERAL (feet is wider) and PERIPHERAL SWELLING (Right foot and calf is swollen). On 10-Feb-2021, the patient experienced VACCINATION COMPLICATION (2 large spot where the injection went in it almost looks like have 2). On 08-Feb-2021, HYPERHIDROSIS (sweating) and CHILLS (Chills) had resolved. On 10-Feb-2021, FATIGUE (fatigue) had resolved. At the time of the report, OEDEMA PERIPHERAL (feet is wider), PERIPHERAL SWELLING (Right foot and calf is swollen) and VACCINATION COMPLICATION (2 large spot where the injection went in it almost looks like have 2) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment details include stockings.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain, Vaccination site pruritus
Clinical narrative: Entire left arm was burning, itching, and pain; Entire left arm was burning, itching, and pain; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Entire left arm was burning, itching, and pain) and VACCINATION SITE PAIN (Entire left arm was burning, itching, and pain) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029K20a) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (Entire left arm was burning, itching, and pain) and VACCINATION SITE PAIN (Entire left arm was burning, itching, and pain). At the time of the report, VACCINATION SITE PRURITUS (Entire left arm was burning, itching, and pain) and VACCINATION SITE PAIN (Entire left arm was burning, itching, and pain) was resolving. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  Treatment details included Hydrocortisone cream, Antihistamine.
Age: 77.0
Sex: F
Vaccine: COVID19, UNK
Symptoms: Abdominal pain upper, Asthenia, Chills, Malaise, Pain in extremity
Clinical narrative: Arm is sore; Very bad stomach ache; Feel very weak; Not feeling well today; Have chills; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY, ABDOMINAL PAIN UPPER, ASTHENIA, MALAISE, and CHILLS in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.    Co-suspect product included non-company product Water for an unknown indication.    no medical history is provided and concomitant drugs are provided.  Concomitant products included PLAVIX for an unknown indication.   On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient started Water (unknown route) at an unspecified dose. On an unknown date, the patient experienced PAIN IN EXTREMITY, ABDOMINAL PAIN UPPER, ASTHENIA, MALAISE, and CHILLS. At the time of the report, PAIN IN EXTREMITY, ABDOMINAL PAIN UPPER, ASTHENIA, MALAISE, and CHILLS outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. Further information has been requested
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chills, Decreased appetite, Feeling abnormal, Headache
Clinical narrative: Another terrible headache; worst headache of her life; weakness; walking around like she got hit by a truck; could not eat; felt awful all day; Chills; nausea; dry heaving; This spontaneous case was reported by a consumer and describes the occurrence of RETCHING (dry heaving), ASTHENIA (weakness), FEELING ABNORMAL (walking around like she got hit by a truck), DECREASED APPETITE (could not eat) and FEELING ABNORMAL (felt awful all day) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Feb-2021, the patient experienced RETCHING (dry heaving), FEELING ABNORMAL (felt awful all day) and NAUSEA (nausea). 04-Feb-2021, the patient experienced CHILLS (Chills). On 07-Feb-2021, the patient experienced DECREASED APPETITE (could not eat). On 08-Feb-2021, the patient experienced ASTHENIA (weakness). 08-Feb-2021, the patient experienced FEELING ABNORMAL (walking around like she got hit by a truck). On 09-Feb-2021, the patient experienced HEADACHE (worst headache of her life). On 10-Feb-2021, the patient experienced HEADACHE (Another terrible headache). At the time of the report, RETCHING (dry heaving), ASTHENIA (weakness), FEELING ABNORMAL (walking around like she got hit by a truck), DECREASED APPETITE (could not eat), FEELING ABNORMAL (felt awful all day), CHILLS (Chills), HEADACHE (worst headache of her life), NAUSEA (nausea) and HEADACHE (Another terrible headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Retching
Clinical narrative: Another terrible headache; worst headache of her life; weakness; walking around like she got hit by a truck; could not eat; felt awful all day; Chills; nausea; dry heaving; This spontaneous case was reported by a consumer and describes the occurrence of RETCHING (dry heaving), ASTHENIA (weakness), FEELING ABNORMAL (walking around like she got hit by a truck), DECREASED APPETITE (could not eat) and FEELING ABNORMAL (felt awful all day) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Feb-2021, the patient experienced RETCHING (dry heaving), FEELING ABNORMAL (felt awful all day) and NAUSEA (nausea). 04-Feb-2021, the patient experienced CHILLS (Chills). On 07-Feb-2021, the patient experienced DECREASED APPETITE (could not eat). On 08-Feb-2021, the patient experienced ASTHENIA (weakness). 08-Feb-2021, the patient experienced FEELING ABNORMAL (walking around like she got hit by a truck). On 09-Feb-2021, the patient experienced HEADACHE (worst headache of her life). On 10-Feb-2021, the patient experienced HEADACHE (Another terrible headache). At the time of the report, RETCHING (dry heaving), ASTHENIA (weakness), FEELING ABNORMAL (walking around like she got hit by a truck), DECREASED APPETITE (could not eat), FEELING ABNORMAL (felt awful all day), CHILLS (Chills), HEADACHE (worst headache of her life), NAUSEA (nausea) and HEADACHE (Another terrible headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Headache, Pyrexia
Clinical narrative: fever; HEADACHE; DIZZINESS; This spontaneous case was reported by a physician and describes the occurrence of DIZZINESS (DIZZINESS), PYREXIA (fever) and HEADACHE (HEADACHE) in a 50-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (DIZZINESS), PYREXIA (fever) and HEADACHE (HEADACHE). At the time of the report, DIZZINESS (DIZZINESS), PYREXIA (fever) and HEADACHE (HEADACHE) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Reporter did not allow further contact
Age: 89.0
Sex: U
Vaccine: COVID19
Symptoms: Vaccination site rash
Clinical narrative: Herpes-Like Rash; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE RASH (Herpes-Like Rash) in an 89-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Previously administered products included for an unreported indication: VACCINES (shingles vaccine).   On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 07-Feb-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced VACCINATION SITE RASH (Herpes-Like Rash). At the time of the report, VACCINATION SITE RASH (Herpes-Like Rash) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chills, Fatigue, Headache, Malaise
Clinical narrative: Chills; Sleepy; Terrible Fatigue; Could not get out of bed; Headache; Not feel good at all; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Terrible Fatigue), ASTHENIA (Could not get out of bed), HEADACHE (Headache), MALAISE (Not feel good at all) and CHILLS (Chills) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Feb-2021, the patient experienced FATIGUE (Terrible Fatigue), ASTHENIA (Could not get out of bed), HEADACHE (Headache) and MALAISE (Not feel good at all). On 10-Feb-2021, the patient experienced CHILLS (Chills) and SOMNOLENCE (Sleepy). At the time of the report, FATIGUE (Terrible Fatigue), ASTHENIA (Could not get out of bed), HEADACHE (Headache), MALAISE (Not feel good at all), CHILLS (Chills) and SOMNOLENCE (Sleepy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Somnolence
Clinical narrative: Chills; Sleepy; Terrible Fatigue; Could not get out of bed; Headache; Not feel good at all; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Terrible Fatigue), ASTHENIA (Could not get out of bed), HEADACHE (Headache), MALAISE (Not feel good at all) and CHILLS (Chills) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Feb-2021, the patient experienced FATIGUE (Terrible Fatigue), ASTHENIA (Could not get out of bed), HEADACHE (Headache) and MALAISE (Not feel good at all). On 10-Feb-2021, the patient experienced CHILLS (Chills) and SOMNOLENCE (Sleepy). At the time of the report, FATIGUE (Terrible Fatigue), ASTHENIA (Could not get out of bed), HEADACHE (Headache), MALAISE (Not feel good at all), CHILLS (Chills) and SOMNOLENCE (Sleepy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: Soreness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Soreness) in a 45-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, the patient experienced PAIN (Soreness). At the time of the report, PAIN (Soreness) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medications were reported No concomitant medications were reported
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Fatigue) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Jan-2021, the patient experienced FATIGUE (Fatigue). At the time of the report, FATIGUE (Fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.    This case was linked to MOD-2021-031421 (Patient Link).
Age: 45.0
Sex: U
Vaccine: COVID19
Symptoms: Injection site pain, Pain
Clinical narrative: body pain; pain in injection site; This spontaneous case was reported by a consumer and describes the occurrence of PAIN and INJECTION SITE PAIN in a 45-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, the patient experienced PAIN and INJECTION SITE PAIN. At the time of the report, PAIN and INJECTION SITE PAIN outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 89.0
Sex: M
Vaccine: COVID19
Symptoms: Dyskinesia, Muscle spasms
Clinical narrative: Started with involuntary jerking of his right arm; m Friday night started involuntary muscle spasms of the right leg more like a jerking motion; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE SPASMS (m Friday night started involuntary muscle spasms of the right leg more like a jerking motion) and DYSKINESIA (Started with involuntary jerking of his right arm) in an 89-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in January 2021.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced MUSCLE SPASMS (m Friday night started involuntary muscle spasms of the right leg more like a jerking motion). On 08-Feb-2021, the patient experienced DYSKINESIA (Started with involuntary jerking of his right arm). At the time of the report, MUSCLE SPASMS (m Friday night started involuntary muscle spasms of the right leg more like a jerking motion) and DYSKINESIA (Started with involuntary jerking of his right arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Neck pain, Pain in extremity, Vaccination site rash
Clinical narrative: big, itchy rash at the injection site; very large lymph node on their neck.; their neck hurt a little; Little arm soreness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Little arm soreness), NECK PAIN (their neck hurt a little), VACCINATION SITE RASH (big, itchy rash at the injection site) and LYMPHADENOPATHY (very large lymph node on their neck.) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032H20A) for COVID-19 vaccination.     No medical history was reported by the reporter.  Concomitant products included BISACODYL (LAXATIN), BUPROPION HYDROCHLORIDE (WELLBUTRIN) and VITAMINS NOS for an unknown indication.    On 31-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Jan-2021, the patient experienced PAIN IN EXTREMITY (Little arm soreness). On 07-Feb-2021, the patient experienced NECK PAIN (their neck hurt a little). On 08-Feb-2021, the patient experienced VACCINATION SITE RASH (big, itchy rash at the injection site) and LYMPHADENOPATHY (very large lymph node on their neck.). At the time of the report, PAIN IN EXTREMITY (Little arm soreness), NECK PAIN (their neck hurt a little), VACCINATION SITE RASH (big, itchy rash at the injection site) and LYMPHADENOPATHY (very large lymph node on their neck.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment details was not reported by the reporter.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: sore arm; A spontaneous report was received from a consumer concerning a 85-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced sore arm.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 19 Jan 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: 039K20A) intramuscularly for prophylaxis of COVID-19 infection.  On an unknown date, the patient experienced the event(s) sore arm.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported./unknown  The outcome of event(s), sore arm was unknown.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Discomfort, Dizziness, Fatigue, Hot flush
Clinical narrative: discomfort; vertigo; dry heaves; dizziness; hot flashes; chills; nausea; tired; This spontaneous case was reported by a consumer and describes the occurrence of DISCOMFORT, VERTIGO, RETCHING, DIZZINESS, and HOT FLUSH in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Vertigo. Concomitant products included METOPROLOL, NEXIUM, DITROPAN, Losartan/ HCTZ, METHENAMINE, REPATHA, JANUVIA, VITAMIN D3, and VITAMIN C for an unknown indication.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced DISCOMFORT, VERTIGO, RETCHING, DIZZINESS, HOT FLUSH, CHILLS, NAUSEA, and FATIGUE. On 04-Feb-2021, DISCOMFORT, VERTIGO, RETCHING, DIZZINESS, HOT FLUSH, CHILLS, and NAUSEA had resolved. On 06-Feb-2021, FATIGUE had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment details included none.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Retching, Vertigo
Clinical narrative: discomfort; vertigo; dry heaves; dizziness; hot flashes; chills; nausea; tired; This spontaneous case was reported by a consumer and describes the occurrence of DISCOMFORT, VERTIGO, RETCHING, DIZZINESS, and HOT FLUSH in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Vertigo. Concomitant products included METOPROLOL, NEXIUM, DITROPAN, Losartan/ HCTZ, METHENAMINE, REPATHA, JANUVIA, VITAMIN D3, and VITAMIN C for an unknown indication.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced DISCOMFORT, VERTIGO, RETCHING, DIZZINESS, HOT FLUSH, CHILLS, NAUSEA, and FATIGUE. On 04-Feb-2021, DISCOMFORT, VERTIGO, RETCHING, DIZZINESS, HOT FLUSH, CHILLS, and NAUSEA had resolved. On 06-Feb-2021, FATIGUE had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment details included none.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: Developed shingles on her right abdomen; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (Developed shingles on her right abdomen) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, the patient experienced HERPES ZOSTER (Developed shingles on her right abdomen). At the time of the report, HERPES ZOSTER (Developed shingles on her right abdomen) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication details were not reported by the reporter. Treatment details was not reported by the reporter.   Reporter did not allow further contact
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site muscle weakness, Joint range of motion decreased, Vaccination site pain
Clinical narrative: muscle weakness at site of injection; could not move the arm; extreme pain at the site of injection / extreme pain on left arm; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE MUSCLE WEAKNESS, JOINT RANGE OF MOTION DECREASED, and VACCINATION SITE PAIN in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029L20A and 012M20A) for COVID-19 vaccination.     Concurrent medical conditions included Asthma and Blood pressure high.   On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INJECTION SITE MUSCLE WEAKNESS, JOINT RANGE OF MOTION DECREASED, and VACCINATION SITE PAIN. At the time of the report, INJECTION SITE MUSCLE WEAKNESS, JOINT RANGE OF MOTION DECREASED, and VACCINATION SITE PAIN outcome was unknown. Not Provided.       The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications reported were blood pressure medicine and asthma medicine. Treatment information were reported as patient went to the doctor and got a pain shot and took medicines.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site pruritus
Clinical narrative: little pain at injection site; redness and itching at the injection site; itchiness at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (itchiness at injection site), VACCINATION SITE ERYTHEMA (redness and itching at the injection site) and VACCINATION SITE PAIN (little pain at injection site) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 31-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (itchiness at injection site). On 07-Feb-2021, the patient experienced VACCINATION SITE ERYTHEMA (redness and itching at the injection site). On an unknown date, the patient experienced VACCINATION SITE PAIN (little pain at injection site). At the time of the report, VACCINATION SITE PRURITUS (itchiness at injection site), VACCINATION SITE ERYTHEMA (redness and itching at the injection site) and VACCINATION SITE PAIN (little pain at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication details were not reported by the reporter. Treatment details was not reported by the reporter.